EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial

Qingling Zhang iD, Xiuhua Fu, Haohui Fang, Jie Lin, Arman Altincatal, Yvonne Huang, Jason H Kwah, Olivier Ledanois, Nanshan Zhong

Journal of Asthma and Allergy · 2026-09 · Volume 19 · 1-13

DOI: 10.2147/jaa.s597499 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Asthma and Allergy, 2026-09. Verfasst von Qingling Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical Uni…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Asia-PacificFEV1corticosteroidsexacerbationlung functionsafety

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, People's Republic of China.
  • Guangzhou National Laboratory, Bioland, Guangzhou, Guangdong, 510005, People's Republic of China.
  • The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, 010000, People's Republic of China.
  • Anhui Chest Hospital, Hefei, Anhui, 230031, People's Republic of China.
  • The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, People's Republic of China.
  • Sanofi, Cambridge, MA, 02139, USA.

ORCID-Profile: Qingling Zhang

Zitieren

APA

Zhang, Q., Fu, X., Fang, H., Lin, J., Altincatal, A., Huang, Y., Kwah, J. H., Ledanois, O., & Zhong, N. (2026). Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial. Journal of Asthma and Allergy, Volume 19, 1-13. https://doi.org/10.2147/jaa.s597499

Vancouver

Zhang Q, Fu X, Fang H, Lin J, Altincatal A, Huang Y, et al. Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial. Journal of Asthma and Allergy. 2026;Volume 19:1-13. doi:10.2147/jaa.s597499

BibTeX
@article{Zhang2026,
  author = {Zhang, Qingling and Fu, Xiuhua and Fang, Haohui and Lin, Jie and Altincatal, Arman and Huang, Yvonne and Kwah, Jason H and Ledanois, Olivier and Zhong, Nanshan},
  title = {Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial},
  journal = {Journal of Asthma and Allergy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--13},
  doi = {10.2147/jaa.s597499}
}
Kostenlos starten →